New hope for stronger bones after spinal injury
NCT ID NCT04708886
Summary
This small, completed pilot study tested a two-step drug treatment to control bone loss in women with chronic spinal cord injury and osteoporosis. Twelve participants received monthly injections of romosozumab for one year to build bone, followed by a year of weekly alendronate pills to help maintain it. Researchers measured changes in bone density and strength using scans and blood tests over the two-year period.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SPINAL CORD INJURIES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Northwestern University Feinberg School of Medicine
Chicago, Illinois, 60611, United States
Conditions
Explore the condition pages connected to this study.